Literature DB >> 8708659

Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.

V Bocola1, G Fabbrini, A Sollecito, C Paladini, N Martucci.   

Abstract

Parkinsonism is a common complication of neuroleptic drug use; however, the pathophysiology of the persistence of parkinsonian symptoms after withdrawal of neuroleptic drugs is poorly understood. Twenty patients with neuroleptic induced parkinsonism were studied by high field MRI. Persistence of symptoms was associated with different findings depending on the age of the patients--namely, putaminal hypointensity in young patients and striatal hyperintensities in old patients. High field MRI may be useful in identifying patients at higher risk for neuroleptic induced parkinsonism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8708659      PMCID: PMC1073810          DOI: 10.1136/jnnp.60.2.213

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  Neuropathological investigation of 28 brains from patients with dyskinesia.

Authors:  E Christensen; J E Moller; A Faurbye
Journal:  Acta Psychiatr Scand       Date:  1970       Impact factor: 6.392

2.  Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?

Authors:  E Melamed; A Achiron; A Shapira; S Davidovicz
Journal:  Clin Neuropharmacol       Date:  1991-06       Impact factor: 1.592

3.  Persistent drug-induced parkinsonism.

Authors:  T A Aronson
Journal:  Biol Psychiatry       Date:  1985-07       Impact factor: 13.382

4.  DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group.

Authors: 
Journal:  Arch Neurol       Date:  1989-10

5.  Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenithixol) in rats.

Authors:  E B Nielsen; M Lyon
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

6.  Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.

Authors:  A H Rajput; B Rozdilsky; O Hornykiewicz; K Shannak; T Lee; P Seeman
Journal:  Arch Neurol       Date:  1982-10

7.  Iron pigment in the brain of a man with tardive dyskinesia.

Authors:  W G Campbell; M A Raskind; T Gordon; C M Shaw
Journal:  Am J Psychiatry       Date:  1985-03       Impact factor: 18.112

8.  Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.

Authors:  D J Burn; D J Brooks
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

9.  Drug-induced parkinsonism in the elderly.

Authors:  P J Stephen; J Williamson
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

Review 10.  Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress.

Authors:  R A Floyd; J M Carney
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

View more
  3 in total

Review 1.  Management of schizophrenia in late life with antipsychotic medications: a qualitative review.

Authors:  Takefumi Suzuki; Gary Remington; Hiroyuki Uchida; Tarek K Rajji; Ariel Graff-Guerrero; David C Mamo
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

Review 2.  Neuroimaging in Vascular Parkinsonism.

Authors:  Karen K Y Ma; Shi Lin; Vincent C T Mok
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

3.  Disentangling dyskinesia from parkinsonism in motor structures of patients with schizophrenia.

Authors:  Katrin Sakreida; Wei-Hua Chiu; Juergen Dukart; Simon B Eickhoff; Thomas Frodl; Christian Gaser; Michael Landgrebe; Berthold Langguth; Daniela Mirlach; Ioana-Sabina Rautu; Markus Wittmann; Timm B Poeppl
Journal:  Brain Commun       Date:  2022-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.